Esther Rajavelu
Chief Executive Officer, Chief Financial Officer and Chief Business Officer · Spero Therapeutics, Inc.
- 2024
- May 7, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Esther Rajavelu files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Timothy Keutzer - $145K in SPRO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Esther Rajavelu?
Esther Rajavelu is a corporate insider, tracked as Chief Executive Officer, Chief Financial Officer and Chief Business Officer of Spero Therapeutics, Inc. (SPRO). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Esther Rajavelu last file a Form 4?
The most recent primary Form 4 on record is dated 7 May 2026, one of 5 filings going back to 2024.
Has Esther Rajavelu been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($460K) across all tracked filings.
